Evidence map›Paper›PMID 31481444›Full record

ArticleAntimicrobial agents and chemotherapy2019

Complete Nucleotide Sequence of a Novel Plasmid Bearing the High-Level Tigecycline Resistance Gene

Liang-Xing Fang, Chong Chen, Dong-Ling Yu, Ruan-Yang Sun, Chao-Yue Cui, Liang Chen, Xiao-Ping Liao, Ya-Hong Liu, Jian Sun

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Genomic characterization of tigecycline-resistantFrontiers in microbiology · 2023
    Article
  4. Mobilization ofAntimicrobial agents and chemotherapy · 2022
    Article
  5. The integrase of genomic island GIFrontiers in microbiology · 2022
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Liang-Xing Fang *National Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, Guangzhou, China.
Chong Chen *National Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, Guangzhou, China.
Dong-Ling Yu *The Teaching and Research Department of Biotechnology, Nanning University, Guangxi, China.
Ruan-Yang SunNational Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, Guangzhou, China.
Chao-Yue CuiNational Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, Guangzhou, China.
Liang ChenHackensack-Meridian Health Center for Discovery and Innovation, Nutley, New Jersey, USA.
Xiao-Ping LiaoNational Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, Guangzhou, China.
Ya-Hong LiuNational Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, Guangzhou, China.
Jian SunNational Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, Guangzhou, China jiansun@scau.edu.cn.ORCID 0000-0002-4209-7555

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We reported the complete nucleotide sequence of a

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialEscherichia coliGenes, BacterialPlasmidsSequence Analysis, DNATigecyclineAnti-Bacterial AgentsTigecyclineEscherichia colihybrid plasmidtet(X4)tigecycline resistance

Identifiers

PMID31481444
PMCPMC6811429

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.